Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Vanguard Total Stock Market Index Fund ETF — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.01 (market cap $1.74B), while Vanguard Total Stock Market Index Fund ETF trades at $382.06 (market cap $2.30T). The key difference: Vanguard Total Stock Market Index Fund ETF is far larger — about 1321.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Vanguard Total Stock Market Index Fund ETF for 131 Days on average.
| NUVB | VTI | |
|---|---|---|
Market Cap | $1.74B | $2.30T |
Volume | 9,289,619 | 2,982,924 |
Sector | Health | — |
52-Week High | $9.54 | $384.30 |
52-Week Low | $3.41 | $311.68 |
Typical Hold Time | 1 Days | 131 Days |
Enterprise Value | $1.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTI trades at $381.82, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF shows strong institutional interest and broad diversification across the U.S. stock market. Recent news highlights its long-term growth potential and cost efficiency, with a dividend scheduled for September 2026.
The outlook for VTI remains positive due to its low-cost structure and exposure to the entire U.S. equity market. Risks include concentration in top holdings and market volatility, but its historical performance supports a solid foundation for long-term investors seeking diversified growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
